<--- Back to Details
First PageDocument Content
Hematopoietic stem cell transplantation / Mesenchymal stem cell / Hematopoietic stem cell / Bone marrow / Embryonic stem cell / Haematopoiesis / Cellular differentiation / Total body irradiation / Allogeneic bone marrow transplantation / Biology / Stem cells / Adult stem cell
Date: 2013-06-29 00:41:25
Hematopoietic stem cell transplantation
Mesenchymal stem cell
Hematopoietic stem cell
Bone marrow
Embryonic stem cell
Haematopoiesis
Cellular differentiation
Total body irradiation
Allogeneic bone marrow transplantation
Biology
Stem cells
Adult stem cell

An overview of stem cells – are they ready for the clinics? Anskar YH Leung Division of Haematology and Bone Marrow Transplantation Department of Medicine Queen Mary Hospital

Add to Reading List

Source URL: hkst.org

Download Document from Source Website

File Size: 2,28 MB

Share Document on Facebook

Similar Documents

What is MDS? (MDS Foundation, 2011) •	 MDS is a group of bone marrow disorders. The bone marrow is the factory for the production of blood cells including red blood cells, white blood cells, and platelets. In MDS, the

What is MDS? (MDS Foundation, 2011) • MDS is a group of bone marrow disorders. The bone marrow is the factory for the production of blood cells including red blood cells, white blood cells, and platelets. In MDS, the

DocID: 1vge2 - View Document

This album evolved in late 2012 and early 2013 when I was recovering from a bone marrow transplant at City of Hope in Duarte, California, where I gratefully had access to the piano in the auditorium every night. One nig

This album evolved in late 2012 and early 2013 when I was recovering from a bone marrow transplant at City of Hope in Duarte, California, where I gratefully had access to the piano in the auditorium every night. One nig

DocID: 1vfid - View Document

ADMINISTRATION OF THE DUAL E-SELECTIN/CXCR4 ANTAGONIST, GMI-1359, RESULTS IN A UNIQUE PROFILE OF TUMOR MOBILIZATION FROM THE BONE MARROW AND FACILITATION OF CHEMOTHERAPY IN A MURINE MODEL OF FLT3 ITD AML Abstract #  2826

ADMINISTRATION OF THE DUAL E-SELECTIN/CXCR4 ANTAGONIST, GMI-1359, RESULTS IN A UNIQUE PROFILE OF TUMOR MOBILIZATION FROM THE BONE MARROW AND FACILITATION OF CHEMOTHERAPY IN A MURINE MODEL OF FLT3 ITD AML Abstract # 2826

DocID: 1uSr7 - View Document

BONE MARROW REQUISITION FOR LAB USE ONLY  Laboratory Director

BONE MARROW REQUISITION FOR LAB USE ONLY Laboratory Director

DocID: 1uLql - View Document

8  Bone marrow drives can save lives THURSDAY, NOVEMBER 19, 2015  BY BRENTLY SNEAD

8 Bone marrow drives can save lives THURSDAY, NOVEMBER 19, 2015 BY BRENTLY SNEAD

DocID: 1uHXj - View Document